These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Spyridopoulos TN; Petridou ET; Skalkidou A; Dessypris N; Chrousos GP; Mantzoros CS; Int J Cancer; 2007 Apr; 120(7):1573-8. PubMed ID: 17205522 [TBL] [Abstract][Full Text] [Related]
4. Serum leptin and adiponectin levels and risk of renal cell carcinoma. Liao LM; Schwartz K; Pollak M; Graubard BI; Li Z; Ruterbusch J; Rothman N; Davis F; Wacholder S; Colt J; Chow WH; Purdue MP Obesity (Silver Spring); 2013 Jul; 21(7):1478-85. PubMed ID: 23666639 [TBL] [Abstract][Full Text] [Related]
5. Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Liao LM; Weinstein SJ; Pollak M; Li Z; Virtamo J; Albanes D; Chow WH; Purdue MP Carcinogenesis; 2013 Jan; 34(1):109-12. PubMed ID: 23042303 [TBL] [Abstract][Full Text] [Related]
6. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial. Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923 [TBL] [Abstract][Full Text] [Related]
7. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis. Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068 [TBL] [Abstract][Full Text] [Related]
8. Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer. Shen XD; Zhang L; Che H; Zhang YY; Yang C; Zhou J; Liang CZ Cytokine; 2016 Jan; 77():50-5. PubMed ID: 26539805 [TBL] [Abstract][Full Text] [Related]
9. A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study. Li F; Zhao H; Hou L; Ling F; Zhang Y; Tan W Int Braz J Urol; 2019; 45(3):523-530. PubMed ID: 30785699 [TBL] [Abstract][Full Text] [Related]
10. The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study. Lindblad P; Wolk A; Bergström R; Persson I; Adami HO Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):631-9. PubMed ID: 7881335 [TBL] [Abstract][Full Text] [Related]
11. History of treated hypertension and diabetes mellitus and risk of renal cell cancer. Zucchetto A; Dal Maso L; Tavani A; Montella M; Ramazzotti V; Talamini R; Canzonieri V; Garbeglio A; Negri E; Franceschi S; La Vecchia C Ann Oncol; 2007 Mar; 18(3):596-600. PubMed ID: 17158772 [TBL] [Abstract][Full Text] [Related]
12. Identifying the emerging role of adipokine as a diagnostic and prognostic biomarker of renal cell carcinoma. Choi SH; Chun SY; Kim TH; Kwon TG Urol Oncol; 2016 Jun; 34(6):259.e15-9. PubMed ID: 26992934 [TBL] [Abstract][Full Text] [Related]
13. Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada. Hu J; Mao Y; White K; Cancer Causes Control; 2003 Oct; 14(8):705-14. PubMed ID: 14674734 [TBL] [Abstract][Full Text] [Related]
14. Association between leptin level and renal cell carcinoma susceptibility and progression: A meta-analysis. Zhu H; Li W; Mao S; Wang L J Cancer Res Ther; 2018; 14(4):873-880. PubMed ID: 29970669 [TBL] [Abstract][Full Text] [Related]
15. History of urinary tract infection and risk of renal cell carcinoma. Parker AS; Cerhan JR; Lynch CF; Leibovich BC; Cantor KP Am J Epidemiol; 2004 Jan; 159(1):42-8. PubMed ID: 14693658 [TBL] [Abstract][Full Text] [Related]
16. The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox". Ito R; Narita S; Huang M; Nara T; Numakura K; Takayama K; Tsuruta H; Maeno A; Saito M; Inoue T; Tsuchiya N; Satoh S; Habuchi T PLoS One; 2017; 12(2):e0171615. PubMed ID: 28178338 [TBL] [Abstract][Full Text] [Related]
17. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome. Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093 [TBL] [Abstract][Full Text] [Related]
18. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study. Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045 [TBL] [Abstract][Full Text] [Related]
19. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961 [TBL] [Abstract][Full Text] [Related]
20. Adipocytokines and breast cancer risk. Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]